Posted by: Oliver Tomas in Health News on July 18th, 2011
Newswise ST. PAUL, Minn. – A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments
Similar Posts:
- Factors that will determine what part D plan to for
- FDA Ties Newer Birth Control Drugs To Blood Clots
- Tai Chi May Help Parkinson’s Patients
- HemoGenix Announces Publication of its White Paper on ?Stem Cells and Predictive In Vitro Toxicity Testing?
- Patient’s Own Blood Being Used to Treat Athletic Injuries
